Curia Recognized on Forbes America’s Best Employers 2022 List
March 24, 2022
ALBANY, N.Y–(BUSINESS WIRE)–Curia a leading contract research, development, and manufacturing organization, today announced that it has been recognized on Forbes list of America’s Best Employers 2022, presented by Forbes and Statista Inc. The awards list can be viewed on the Forbes website.
Over the past 12 months, Curia has continued to advance its people excellence strategy, focused on unleashing the individual and collective talents of its employees toward building an inclusive, and high-performing culture. The company expanded its global Learning Initiatives for Employees program – known as LIFE@Curia – and strengthened its focus on diversity, equity, and inclusion (DE&I) by implementing six DE&I pillars. With a commitment to continuous improvement, leaders also prioritized work practices to improve, as identified by employees through its enhanced annual engagement survey.
“Last year was transformative for Curia, and we welcomed many employees to our organization with a new brand and renewed commitment to our patient-centered mission,” said Curia Chairman and CEO John Ratliff. “I’m proud of our recognition in the Forbes ranking. It reflects the commitment and talent of the entire Curia community, which has grown and delivered throughout the course of another challenging year. Together, we continued in our dedication to making an impact on patients’ lives.”
Forbes and Statista selected America’s Best Employers 2022 through an independent survey applied to a sample of approximately 60,000 American employees working for companies with more than 1,000 employees. Across 25 industry sectors, 1,000 employers have been awarded, 500 large employers and 500 midsize employers. The evaluation was based on direct and indirect recommendations from employees who were asked to rate their willingness to recommend their own employer to friends and family. Employee evaluations also included other employers in their respective industries that stood out either positively or negatively.
Curia, formerly is a leading contract research, development, and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers. Curia’s 3,700 employees at 29 locations across the U.S., Europe, and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.
More from Curia
September 15, 2023
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA)